Captiva Verde Land Corp Announces Solargram Farms Corporation Receives Health Canada Standard Cultivation Cannabis License for Renauds Mills, New Brunswick

Coquitlam, British Columbia, Jun 30, 2020 – (ACN Newswire) – Captiva Verde Land Corp. (CSE: PWR) (the "Company") is extremely pleased to announce that Solargram Farms Corporation ("Solargram"), a Canadian controlled private corporation, having corporate offices in Moncton, NB has officially received its Standard Cultivation Cannabis License from Health Canada. The license was issued in accordance with the Canadian Cannabis Act and Cannabis Regulations. 100% of the Solargrams shares are held in an escrow account ready to be transferred to Captiva Verde in exchange for 35 Million Captiva shares subject to a tight pooling agreement, subject to Health Canada approving the application by all the Captiva Verde officers and directors to pass a security clearance and CSE approval.

Under this Health Canada License, Solargram is now authorized at its site location to conduct the activities listed below:

– From its indoor-area special purpose, state of the art Greenhouse facility: cultivation, propagating, testing, harvesting, and selling cannabis,
– From its custom designed, massive outdoor farm grow area: cultivation, propagation, and harvesting cannabis.

It has taken Solargram eighteen (18) months to have achieved this major milestone while recently completing final installation of its New Brunswick 5.6 million square feet grow infrastructure build out located in Renauds Mills, New Brunswick in anticipation of receiving its Standard Cannabis Cultivation License.

The CEO of Captiva Verde Jeff Ciachurski states: "With this exciting news release I declare my intention to purchase 500,000 additional shares of Captive Verde on the open market and as CEO of Greenbriar Capital Corp (which already owns 10.7 million shares of Captiva Verde) declares its intention to seek Toronto Venture Exchange approval to purchase an addition 3 million shares of Captiva Verde on the open market.

Renauds Mills Site Infrastructure Buildout Results

Over the last six months through the best winter and spring conditions in the area in over a decade, the extremely dedicated and focused Solargram team led by Len Wood, Executive Vice President Captiva Verde and Vice President Solargram Farms, and Marc LeBlanc, President Solargram Farms, have amazingly achieved:

– Installation of over 8,000 feet of security perimeter fencing over approximately 50 acres,
– Implementation of one of Canada's top robust, lowest-cost outdoor farm grown cannabis cultivation facilities having significant, highly cost efficient, infrastructure assets,
– Purchasing and integrating an approximate 130 land acres package together with an onsite six million gallon water holding pond as well as high capacity water wells to self-serve our planned cannabis outdoor grow farm,
– Purchasing, renovating, and repurposing three onsite buildings totalling over 36,000 square feet, allowing for vertically integrated seed-to-sale, onsite propagating mothers and clones, de-bucking, milling, drying, and extraction operation capabilities for 2020 and beyond. Outdoor farm cannabis crop planting now underway to produce an expected year one 10,000+ kg's of dried cannabis over 25 acres (1,100,000 square feet) with combination hoop house crop coverage including specific designed additional micro climate grow areas to achieve for increased crop protection and maximization of cannabis grow cultivation yield.
– Site infrastructure buildout was fully funded, completed on time, and was completed 65% under original capital budget. We remain completely debt free, and are now funded for our 2020 grow season.

Len Wood states, "Marc and I wish to congratulate all of our team members for their immense effort and dedication in aiding Solargram to achieve this amazing Health Canada licensing milestone. We have truly created an operation that is built for success based on sound business practices including fiscal responsibility as well as planned positive sustainable operating cash-flows, which is a real business. We wish to thank all of our loyal stakeholders that have continued to support our vision while understanding our mission to create a unique Canadian Licenced Producer cannabis market leader that will show and demonstrate the business model required to produce sustainable positive annual cash flow profits, while providing enhanced returns for our shareholders."

Captiva Verde is proud that the company has now positioned Solargram's world class team of experienced operators and growers with a financially debt-free, fully developed set of land assets, growing assets, buildings, proprietary IP and technological expertise to successfully run and operate significantly planned, vertically integrated, cannabis outdoor grow farm land acreages at a planned and budgeted ultra-low sub $0.25 production grow cost per gram. Outdoor grow is a major market disruptor and differentiator and this will allow Solargram to sell its planned high cannabinoid full spectrum cannabis oil products at prices that are significantly below its competitors cost of production as well as below black market pricing. Outdoor is a game changer and will allow our company to become an effective leader in this market.

Solargram has a five year planned outdoor farm grown production capacity in excess of 130 farm acres at the Renaud Mills New Brunswick outdoor grow site alone representing over 65,000 kg's of dried cannabis targeted for end product full spectrum cannabis oil (THC, THCV, CBD, CBG, CBD-THC) concentrate for export as well as for end product, best in class unique cannabis and edible products.

According to The Guardian less than 10% of Canada's current legal cannabis products are derived from outdoor operations. Sun grown outdoor plants have the lowest cost with consistent high yields and potency, providing consumers with an opportunity to choose from a selection of natural and healthier products than what the market currently offers. Publicly released results from three (3) Canadian outdoor licensed grow facilities in 2019 reported cash costs of between eight (8) cents to twenty-four (24) cents per gram. The new successful companies like Solargram, can provide both a superior product and a price point, inclusive of taxes, that is well below the black market rates, which the latter currently outperforms the legal market at a rate of more than three to one.

Solargram embraces the experiences of long time growing veterans, scientist and proven business leaders whose collective experience together, puts cannabis where its intention is most valued, to the trusted consumer. Cannabis is an evolutionary business within a revolutionary change of politics. The torch is being handed back to veteran growers, scientist and proven business leaders who understand the original intent of legalization, which is to have the lowest cost, first in class products available to everyone.

On Behalf of the Board of Directors
"Jeff Ciachurski"
Jeffrey Ciachurski
Chief Executive Officer and Director
Cell: (949) 903-5906
E-mail: westernwind@shaw.ca

Cautionary Note Regarding Forward Looking Information

This release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include regulatory actions, market prices, and continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

Copyright 2020 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Tobacco Harm Reduction Advocates Say They Want Australian Ban on Liquid Nicotine Aborted, Not Delayed

BANGKOK, Jun 29, 2020 – (ACN Newswire) – Tobacco harm reduction advocates across Asia-Pacific called on the Parliament of Australia to abort, not delay, the planned ban on imports of liquid nicotine for vaping to provide smokers with alternatives to combustible cigarettes. Factasia, a non-profit regional tobacco harm reduction consumer advocacy, said e-cigarettes or vapes, along with other smoke-free nicotine products such as heat-not-burn tobacco products and snus, have the ability to significantly reduce the health risks of millions of Australian smokers.





"This is a technology that needs to be regulated, not restricted and banned. Adult consumers should be able to access a choice of regulated devices and liquids, including those containing nicotine. Underage use should be effectively and comprehensively banned," Factasia founder Heneage Mitchell said in separate letters sent to Australia's members of parliament.

Mitchell made the statement even as Health Minister Greg Hunt decided to postpone the ban on imports of liquid nicotine by six months amid opposition from vapers, consumer groups, tobacco harm reduction experts and even members of Parliament. This means that the ban will now be delayed to 1 January 2021 from the original plan of 1 July 2020.

Mitchell said MPs should instead push for the regulation of e-cigarettes and other smoke-free nicotine products that can substantially reduce the risks suffered by smokers from the tar – the byproduct of smoke.

"Consumers need to be truthfully and fully informed of the life-saving potential of vaping and granted access to a choice of regulated harm-reduced nicotine products which, at the moment, in Australia, they are not," Mitchell said.

"To be clear, there has never been a recorded death from vaping-regulated nicotine products since the introduction of the e-cigarette in 2001. But over the same period of time, more than 130 million smokers worldwide have died from tobacco-related illnesses and disease. They include many hundreds of thousands of our Australian brothers and sisters," he said.

Ines Hage Nebyl from the Office of Tim Wilson MP acknowledged the receipt of the letter from Factasia and assured that Wilson remains a well-established supporter of allowing people to vape.

"In the last Parliament, he was part of an inquiry into the health impacts and regulation of vaping. The committee opposed legalisation and regulation. Tim was part of a dissenting report arguing the law should change as a regulated product. That was his view then. That is his view now. Tim's views have not changed; he wants people off tobacco. Further to this, Tim has expressed his views to the minister on the recent action, and will continue to do so," Nebyl said.

Wilson is among the politicians who opposed the ban on vaping, which they felt would encourage vapers to return to smoking. Sydney Morning Herald reported that 28 Coalition MPs and senators signed a petition opposing the ban on the importation of vaping products containing nicotine.

In a statement on 26 June 2020, Hunt said the delayed implementation of the ban aimed to help the group of people who have been using e-cigarettes with nicotine as a means to ending their cigarette smoking.

"In order to assist this group in continuing to end that addiction, we will therefore provide further time for implementation of the change by establishing a streamlined process for patients obtaining prescriptions through their GP," the minister said.

Tobacco harm reduction advocates said Hunt's statement provided them an opportunity to advocate for legalization and regulation of nicotine vaping in Australia, which has nearly 500,000 vapers, according to some estimates.

Mitchell said Hunt should review scientific evidence showing that vaping is 95 percent safer than smoking, as shown in the evidence review carried out by Public Health England, and is regarded as the most effective method of smoking cessation available to smokers by a vast number of researchers, medical professionals, genuine tobacco control experts and governments who looked at the evidence, including the U.K., the EU, Canada, New Zealand, Japan, Korea, the U.S., and recently, Hong Kong.

"The countries listed above continue to see historic declines in the number of citizens smoking as they switch to these far less harmful technologies," he said.

The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) said it is time for MPs to reject the ban.

"In Australia, 21,000 citizens die every year from smoking-related disease. We feel that Australians who have made the informed choice to switch to alternative nicotine consumption, such as e-cigarettes, need to be heard by their elected representatives," said CAPHRA Executive Coordinator Nancy Loucas.

Loucas noted that in neighboring New Zealand, the Ministry of Health concluded that the effects that punitive regulation would have on the people who had chosen to move away from combustible cigarettes would be negative.

Other groups have also expressed their opposition to the ban, including the Australian Tobacco Harm Reduction Association (ATHRA), the Progressive Public Health Alliance (PPHA), Aotearoa Vape Community Advocacy (AVCA) and Legalise Vaping Australia (LVA).

About Factasia

factasia.org is an independent, not-for-profit, consumer-oriented advocate for rational debate about – and sensible regulation of – the rights of adult citizens throughout the Asia-Pacific region to choose to use tobacco or other nicotine-related products.

About CAPHRA

The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) is an alliance of consumer organizations from Australia, Hong Kong, India, Indonesia, Malaysia, New Zealand, the Philippines, South Korea, Taiwan and Thailand that aims to educate, advocate and represent the right of adult alternative nicotine consumers to access and use of products that reduce harm from tobacco use.

MEDIA CONTACT:
Jena Fetalino, JFPRC jena@jfprc.com, +639178150324

Push for Regulation

MPs should instead push for the regulation of e-cigarettes and other smoke-free nicotine products that can substantially reduce the risks suffered by smokers from the tar – the byproduct of smoke.

Copyright 2020 ACN Newswire. All rights reserved. http://www.acnnewswire.com

GFI APAC announces the “2020 Asia Alt 100” Industry Disruptors in Alternative Protein

HONG KONG, Jun 22, 2020 – (ACN Newswire) – The Good Food Institute Asia-Pacific (GFI APAC) today reveals the "2020 Asia Alt 100" organizations, together with a list of major investors identified as the driving forces for Asia's rapidly growing alternative protein industry. The raw materials and food production segments present significant opportunities, especially for regional industry players, according to GFI APAC's analysis.



GFI APAC Elaine Siu



The inaugural "Asia Alt 100" list published by GFI APAC identifies the 100 top players in Asia's alternative protein industry, from five building block segments, namely raw materials and ingredients, food production, research and development, corporate partnership, to end products. The research covers players in major markets in Asia including mainland China, Hong Kong, Singapore, Japan and South Korea. (Please see the full list in Appendix I)

Investment in alternative protein has been a major trend in the food industry worldwide in recent years. While alternative protein may still be in its infancy stage in Asia, compared to more mature markets such as the U.S. where plant-based retail sales already reached US$5 billion in value , there are unique opportunities in the growing Asia market to be captured, and both corporates and start-ups are clearly keen to compete for a share in this growing segment. Out of the "2020 Asia Alt 100", over half (57%) are corporates, 29% are start-ups, while the remaining 14% are academic institutions.

"Coming from a background of very vibrant and diversified food cultures, Asian consumers have a discerning palate and demand for a great variety when it comes to food. For alternative protein to truly become a protein solution for Asia, the industry needs to move beyond importing technologies and brands from Silicon Valley. We need homegrown players who understand and can cater to the local markets' taste," says Elaine Siu, Managing Director of GFI Asia Pacific.

"We have already seen local innovators and companies starting to emerge in the past year with huge potential to lead the future growth of this sector. With the Asia Alt 100, we have identified the ones we see as the top disruptors in the industry which have demonstrated that they are seriously committed to, and invested into, growing the alternative protein industry."

The Asia Alt 100 is presented in GFI APAC's Asia Alternative Protein Industry Map, which shows who these key players are and how they work together, alongside a list of 35 key investors in the field. Investors are another very important building block propelling the developments of alternative protein in Asia. They come from around and outside of Asia, including Singapore (10), Hong Kong (6), Japan (5), mainland China (4), South Korea (1), other southeast Asian countries (2) and outside of Asia (7). Twenty-eight out of the 35 investors identified are venture capital firms, while the remaining seven are accelerators. (Please refer to Appendix II for the full list of investors).

According to Siu, "While major consumer brands and retailers launching the 'next plant-based burger' have been getting the spotlights, as the industry matures, we have seen investors showing increasing interests in raw materials and ingredients suppliers and B2B companies." Both raw materials and production are integral parts of the alternative protein value chain, but the market is only just catching up on discovering the opportunities that lie in the upper stream. For example, currently Asian countries such as China and Indonesia are heavily growing plant-based protein's raw materials such as soybean and peas, while approximately 50% of the global supply of soy protein is being processed in mainland China, mainly in the Shandong and Henan regions.

Currently, about half (58%) of the raw material and ingredient suppliers in the 2020 Asia Alt 100 list are originated in Asia. If more homegrown players from Asia will enter the market to leverage the proximity to raw materials and processing capabilities, the industry as a whole can potentially bring down production costs to make alternative protein more affordable to Asian consumers and accelerate the development of the alternative protein sector in Asia.

Siu concludes: "We are currently at an exciting phase of accelerating growth in the alternative protein in Asia. It is expected that more and more Asian companies will enter the industry as the local players start to realize the competitive advantage they have in growing raw materials, processing ingredients, local distribution network, supply chain infrastructure, and of course, in creating products that are tailored to the variety of Asian palate and culture."

Note:
The team at GFI APAC is in a unique position to have their finger to the pulse of the industry. Day in day out the team is consulted by startups (in many cases even before they formed their founding team), corporates, investors, scientists, and policymakers, free of charge. Being privy to and trusted with invaluable information, the GFI APAC team has the inside track to identify the top players that have demonstrated that they are seriously committed to, and invested into, growing the alternative protein industry, and deserve a place in the "Asia Alt 100" list.

Details of the scope of this study are as follows:

– Regions
Included: Major markets in Asia e.g. Singapore, mainland China, Hong Kong, Japan, South Korea.
Excluded: India

– Businesses
Included: Raw materials and ingredients, food production, research and development, and corporate partners. In line with our goal to increase transparency and awareness of the makers in the supply chain.
Excluded: Retailers and food service providers.

– Local Presence
Included: Companies incorporated in Asia, and companies incorporated outside of Asia but have built a local presence or otherwise invested significantly in Asia.
Excluded: Companies incorporated outside of Asia and without a local presence or significant investment in Asia, notwithstanding that their products may be available in Asia via distributors.

Mapping the Industry

This year, GFI APAC presents the 2020 Asia Alt 100 alongside 35 investors on the Asia Alternative Protein Industry Map to showcase not only the who's who of this sector but how they work together. Please view the full map at the following link: http://www.gfi-apac.org/asia-alt-100/

About The Good Food Institute (GFI)

The Good Food Institute is an international non-profit building a sustainable, healthy, and just global food system. With unique insight across the scientific, regulatory, industry, and investment landscape, we are accelerating the transition of the world's food system to alternative proteins using the power of food innovation and markets. For more information, please go to: http://www.gfi-apac.org/

Media Contact
Viola Chen
Direct: +852 5426 0552
Email: violac@gfi.org

Investor Contact
Elaine Siu
Direct: +852 9872 1690
Email: elaines@gfi.org

Appendix I: 2020 Asia Alt 100 – Full List (by alphabetical order)

1. AAK https://www.aak.com/
2. ADM https://www.adm.com/
3. Agency for Science, Technology and Research (A*STAR) https://www.a-star.edu.sg/
4. Avant Meats http://www.avantmeats.com/
5. Avebe https://www.avebe.com/
6. Awano Food Group http://awanofood.com/
7. Axiom Foods http://axiomfoods.com/#
8. Baicaowei https://www.vipbcw.com/
9. Beijing Technology & Business University http://english.btbu.edu.cn/
10. Betagro Group http://www.betagro.com/intro
11. Beyond Meat https://www.beyondmeat.com/
12. Buhler https://www.buhlergroup.com/content/buhlergroup/global/en/homepage.html
13. Calysta http://calysta.com/
14. Cargill https://www.cargill.com/
15. Cellivate Technologies https://www.cellivate.xyz/
16. Charoen Pokphand Foods https://www.cpfworldwide.com/en/home
17. DAIZ https://www.daiz.inc/
18. Danisco (China) Investment https://www.bloomberg.com/profile/company/ACHDOZ:CH
19. DSM https://www.dsm.com/corporate/home.html
20. Duoning Biotech https://www.duoningbio.net/
21. DuPont https://www.dupont.com/
22. Fuji Oil https://www.fujioil.co.jp/en/index.html
23. Givaudan https://www.givaudan.com/
24. Glico Nutrition https://www.glico.com/nutrition/en/
25. Growthwell Group http://growthwellfoods.com/
26. Hey Maet http://heymaet.com/
27. Hongchang Biotech (Suzhou) http://en.hongchangfood.cn/
28. Impossible Foods https://impossiblefoods.com/
29. Ingredion https://www.ingredion.com/
30. Integriculture https://integriculture.jp/?locale=en
31. Japan Science and Technology Agency (JST) https://www.jst.go.jp/EN/
32. Jiangnan University http://english.jiangnan.edu.cn/
33. Jinnong http://www.jinnongbio.com/html/en/
34. Jinzi Ham https://www.reuters.com/companies/002515.SZ
35. JUST https://www.ju.st/en-us
36. Kagoshima University https://www.kagoshima-u.ac.jp/en/
37. Karana https://eatkarana.com/
38. Kerry https://www.kerrygroup.com/
39. KosmodeHealth https://kosmodehealth.com/
40. Lesaffre https://www.lesaffre.com/
41. Let's Plant Meat https://www.letsplantmeat.co/
42. Life 3 Biotech https://www.life3.co/
43. Loma Linda https://atlanticnaturalfoods.com/loma-linda/
44. Marvelous Foods https://marvelousfoods.com/
45. Mitsui Co https://www.mitsui.com/jp/en/index.html
46. Monde Nissin https://www.mondenissin.com/
47. Nanjing Agricultural University http://english.njau.edu.cn/
48. Nanjing Zhouzi Future Food http://www.js.xinhuanet.com/2020-01/22/c_1125492974.htm
49. Nanyang Technological University (NTU) https://www.ntu.edu.sg/Pages/home.aspx
50. National University of Singapore (NUS) http://www.nus.edu.sg/
51. Nestle https://www.nestle.com/
52. NH Foods https://www.nipponham.co.jp/eng/
53. Ningbo Sulian Food https://tinyurl.com/yavte3nz
54. Nishimoto Co. https://www.wismettac.com/en/index.html
55. Nissin Foods https://www.nissin.com/en_jp/
56. Omni Foods https://omnipork.co/
57. Otsuka Food https://www.otsuka.com/en/rd/consumer/
58. Pepsico https://www.pepsico.com/
59. PFI Foods http://www.pfifoods.com/
60. Phuture Foods http://phuturemeat.com/
61. Phyto Corporation https://www.phytoco.com/
62. Pulmuone https://www.pulmuonefoodsusa.com/
63. Quorn https://www.quorn.co.uk/about-quorn/protein
64. Robobank https://www.rabobank.com/en/home/index.html?languageDoesNotExists=zh
65. Roquette https://www.roquette.com/
66. Shanxi Nutranovo http://www.nutranovo.com/
67. Shinshu University https://www.shinshu-u.ac.jp/english/
68. Shiok Meats https://shiokmeats.com/
69. Shuangta Food http://en.shuangtafood.com/
70. SiCell https://tinyurl.com/y7wav6nj
71. Sophie's BioNutrients https://www.linkedin.com/in/eugene-wang-2957b86/
72. South China University of Technology https://www.scut.edu.cn/en/
73. SPC Samlip http://www.spc.co.kr/spc/eng/group/GF_samlip.spc
74. Starfield https://www.starfieldcn.com/
75. Sumitomo Corporation https://www.sumitomocorp.com/en/jp
76. Supersun http://supersunvegefood.lk/
77. Tereos https://tereos.com/en/#
78. TerViva https://www.terviva.com/
79. The Chinese University of Hong Kong https://www.cuhk.edu.hk/english/index.html
80. The PlantEat https://theplanteat.github.io/
81. Tianjin Norland http://www.norlandbiotech.com/
82. Tokyo Medical and Dental University http://www.tmd.ac.jp/english/
83. Tokyo Women's Medical University http://www.twmu.ac.jp/english/
84. Toriyama Chikusan Shokuhin https://umami-wagyu.com/
85. Triton Algae Innovation https://www.tritonai.com/
86. Tupac.Bio https://tupac.bio/index.html
87. Turtletree Labs https://turtletreelabs.com/
88. UCDI https://www.co2.co.jp/english/
89. University of Tokyo https://www.u-tokyo.ac.jp/en/
90. Unlimeat https://tinyurl.com/yap9cygn
91. Veego https://tinyurl.com/ycz8f6ody
92. Vegetari Healthy Bites https://www.vegetari.ph/
93. Vesta http://www.vestafoodlab.com/
94. Whole Perfect Food / Qishan http://www.qishanfoods.com/index.html
95. Wilmar International https://www.wilmar-international.com/
96. Worth The Health Foods https://www.wthfoods.ph/
97. Z-Rou http://www.z-roumeat.com/
98. Zero Meat https://zeromeat.jp/
99. Zhen Meat https://zhenmeat.com/en
100. Zikooin https://zikooin-market.com/

Appendix II: Key investors – Full List (by region)

1. Brinc Hong Kong https://www.brinc.io/
2. Green Monday Ventures Hong Kong https://greenmonday.org/en/ventures/
3. Horizons Ventures Hong Kong https://www.horizonsventures.com/
4. Lever VC Hong Kong https://www.levervc.com/
5. Vectr Ventures Hong Kong https://vectr.co/
6. VU Venture Partners Hong Kong https://www.vuventurepartners.com/
7. Bits X Bites. Mainland China http://www.bitsxbites.com/
8. Dao Foods Mainland China https://www.daofoods.com/
9. Joy Capital Mainland China http://www.joycapital.com.cn/en
10. Matrix Partners China Mainland China https://www.matrixpartners.com/
11. Beyond Next Ventures Japan http://beyondnextventures.com/en/
12. Glocalink Japan https://en.glocalink.com/
13. Hiroshima Venture Capital Japan https://www.h-vc.co.jp/
14. RealTech Fund Japan https://www.realtech.fund/en/
15. Yakumi Investment Japan https://www.yakumi.co/
16. Big Idea Ventures Singapore https://bigideaventures.com/
17. DSG Consumer Partners Singapore https://dsgcp.com/
18. Germi8 Singapore https://www.germi8.com/
19. GROW Singapore https://www.gogrow.co/
20. Hatch Singapore https://www.hatch.blue/
21. ID Capital Singapore https://www.idcapital.com.sg/
22. Innovate 360 Singapore http://innovate360.sg/
23. Makana Ventures Singapore https://www.makanaventures.com/
24. Temasek Singapore https://www.temasek.com.sg/en/index
25. VisVires New Protein Singapore https://www.visviresnewprotein.com/
26. Mirae Asset Global Investments South Korea https://www.am.miraeasset.com/
27. Space-F Other SEA https://www.space-f.co/
28. Thai Union Other SEA https://www.thaiunion.com/en/home
29. Agfunder Out of Asia https://agfunder.com/
30. Artesian Capital Out of Asia https://www.artesianinvest.com/overview-vc
31. Blue Horizon Out of Asia https://www.bluehorizon.com/
32. New Crop Capital (NCC) Out of Asia https://www.linkedin.com/company/new-crop-capital/
33. Tyson Ventures Out of Asia https://www.tysonfoods.com/innovation/food-innovation/tyson-ventures
34. Unovis Partners Out of Asia https://www.unovis.vc/
35. VegInvest Out of Asia https://www.veginvesttrust.com/


Copyright 2020 ACN Newswire. All rights reserved. http://www.acnnewswire.com

CropLife Asia Commends UN Call for Action to Avoid “Global Food Emergency” & Rallies Regional Stakeholders

SINGAPORE, Jun 11, 2020 – (ACN Newswire) – A policy brief released this week by the United Nations (UN), "The Impact of COVID-19 on Food Security and Nutrition", raises serious concerns regarding the effect COVID-19 is having on the most vulnerable parts of society already experiencing hunger and malnutrition. As a result, CropLife Asia is reiterating the need for greater coordination and collaboration across the regional food value chain to ensure a sustainable supply of safe and nutritious food.

Last year, the UN issued research indicating hunger, undernourishment and obesity are at critical levels globally and throughout Asia in particular. According to the 2019 State of Food Security & Nutrition in the World, some 820 million people did not have enough food to eat in 2018 – this was up from 811 million in 2017 and represented the third consecutive year of increase. Meanwhile, over 513 million of those hungry people (or over 62%) call Asia home. When it came to undernourishment, the statistics were also discouraging. In 2018, the largest number of undernourished people around the world (more than 500 million) lived in Asia.

"We're seeing first-hand the diabolical disruption COVID-19 continues to cause our food supply chain in Asia. This UN brief only reaffirms the effect the pandemic is having and heightens the needs for action," said Dr. Siang Hee Tan, CropLife Asia Executive Director.

"CropLife Asia commends the UN for its leadership on this critically important issue. From farm to fork, we all have a role to play in ensuring a safe and nutritious supply of food reaches those who need it most. It's time for the regional stakeholders driving the food supply chain to answer this clarion call by the UN and work together to ensure a food emergency isn't realized in Asia. It's time for greater coordination and collaboration among governments, industries and civil society to deliver results. It's time to get to work."

Feeding our growing global population is a shared responsibility, and plant science continues to play a crucial role. Biotech crops are developed with improved traits such as increased yield, better resistance to pests and/or improved nutrition, among others. These traits are crucial tools that enable farmers to meet global challenges such as food insecurity. Meanwhile, farmers continue to rely on crop protection products to produce more food on less land and raise productivity per hectare. Without crop protection products, 40 percent of global rice and maize harvests could be lost every year[1] and losses for fruits and vegetables could be as high as 50-90 percent.

About CropLife Asia

CropLife Asia is a non-profit society and the regional organization of CropLife International, the voice of the global plant science industry. We advocate a safe, secure food supply, and our vision is food security enabled by innovative agriculture. CropLife Asia supports the work of 15 member associations across the continent and is led by six member companies at the forefront of crop protection, seeds and/or biotechnology research and development. For more information, visit us at www.croplifeasia.org.

For more information please contact:
Duke Hipp
Director, Public Affairs
CropLife Asia
Tel: +65 6221 1615
duke.hipp@croplifeasia.org

Copyright 2020 ACN Newswire. All rights reserved. http://www.acnnewswire.com

New Study Underscores How Heated Tobacco Products Are Disrupting the Cigarette Industry

MANILA, May 31, 2020 – (ACN Newswire) – A new study shows that the entry of heated tobacco products (HTPs) triggered a remarkable reduction in combustible cigarettes sales in Japan. "The decline in smoking rates among adults in Japan is astoundingly impressive when you realize that this has only come about rapidly with the introduction of HTPs," said Nancy Loucas, Executive Director of the Coalition of Asia-Pacific Tobacco Harm Reduction Advocates (CAPHRA).



Prof. David Sweanor, one of the study's authors



Canadian and American researchers looked at how trends in the sale of cigarettes in Japan between 2011 and 2019 correspond to the sales of HTPs that were introduced into the Japanese market in late 2015. Using data from the Tobacco Institute of Japan and Philip Morris International (PMI), the researchers concluded that the accelerated five-fold decline in cigarette only sales in Japan since 2016 corresponds to the introduction and growth in the sales of HTPs. Cigarette sales in Japan were declining slowly and steadily before HTPs were introduced in 2015.

Entitled "What Is Accounting for the Rapid Decline in Cigarette Sales in Japan?", the study was published on May 20, 2020 in the peer-reviewed open access scientific journal International Journal of Environmental Research and Public Health.

HTPs are smoke-free devices that heat, instead of burn, specially-designed tobacco units to release a flavorful nicotine-containing tobacco vapor. As tobacco is not burned, the levels of harmful chemicals produced by HNB products are significantly lower compared to combustible cigarette smoke. The most popular HTP brand is IQOS, a product of PMI.

Consumers' interest and the regulatory environment shape markets, according to Professor David T. Sweanor of the Faculty of Law of University of Ottawa, one of the study's authors. He explained that Japanese regulations precluded alternatives to combustible cigarettes, such as nicotine-containing vaping products. However, HTPs generated huge interest among smokers in Japan. "As more [smokers] adopted the alternative, they helped speed switching by others. I think this gives us an indication of just how much more rapidly countries could reduce cigarette use if there were many different low-risk alternatives available and policies and public education campaigns facilitated a widespread move away from [combustible] cigarettes."

Prof. Sweanor believes Japan is a success story in tobacco harm reduction.

"We have seen the most rapid decline in cigarette sales ever witnessed in a major market. A third of the cigarette market was gone in a remarkably short period of time, and this was accomplished with a non-coercive measure. People who smoke cigarettes were simply provided with a viable alternative."

Governments in the Asia Pacific region that seek to ban or limit the access of smokers to HTPs and other safer nicotine alternatives should look to Sweden which for decades has promoted the shift to low-risk non-combustible alternatives to cigarettes, said Prof. Sweanor. "Now we have evidence that a range of low-risk products can help us rapidly achieve the smoking rate targets of the World Health Organization's Sustainable Development Goals. To seek to ban or limit access to such products protects the cigarette industry rather than public health."

Commenting on the future of smokers in Asia Pacific where HTPs will soon be available, Prof. Sweanor stressed that policies should empower people to take control of their health. "Ensuring that a range of low-risk alternatives are not only on the market but have regulatory and tax advantages over cigarettes has the potential to transform public health. We have long known that people smoke for nicotine but die from the smoke. Cigarette smoking is a public health catastrophe that can be massively reduced through science and technology if policies can be oriented toward replacing rather than protecting the cigarette business."

The publication of the new study is timely as it comes on the heels of the celebration of World Vape Day on May 30, 2020. Observed a day before World No Tobacco Day, World Vaping Day aims to raise awareness on e-cigarettes or vapes and encourage smokers who are unable to quit on their own or with currently available smoking cessation tools to switch to safer nicotine products.

"Safer nicotine products, such as e-cigarettes and heated tobacco products, are the most disruptive influence on smoking in decades. These are the innovations that have the potential to save millions of lives in the Asia Pacific region as well as globally," added Nancy Loucas.

According to Loucas, the most popular form of safer nicotine products in northern Asia are HTPs. Like Japan, Korea has shown similar sales and uptake of HTPs, with corresponding declines in combustible tobacco use. These data show that the substitution of combustible tobacco with reduced-risk products has the potential to be a highly effective tobacco harm reduction strategy, she explained. "So, it is very disheartening that countries in Asia Pacific, like Korea and the Philippines, are looking to either ban and/or reduce access and choice of all forms of tobacco harm reduced products for their smoking citizens."

"Japan's success in reducing smoking prevalence through HTPs should be a wakeup call to local policymakers. Quit or die aren't the only choices for smokers," said Peter Paul Dator, president of The Vapers Philippines.

"This new study lends further credence to adopting tobacco control policies based on a harm reduction model," said Stephanie Thuesen, Director of Stakeholder Engagement at The Progressive Public Health Alliance in Australia.

"Policymakers in Thailand, which has been ranked the worst country in the world to be in if you are a vaper, should listen to Prof. Sweanor. Banning or limiting access to safer nicotine products only serve to protect the cigarette industry rather than public health," said Asa Ace Saligupta who runs the ECST.

About CAPHRA

The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) is an alliance of consumer organizations from Australia, Hong Kong, India, Indonesia, Malaysia, New Zealand, the Philippines, South Korea, Taiwan and Thailand that aims to educate, advocate and represent the right of adult alternative nicotine consumers to access and use of products that reduce harm from tobacco use.

MEDIA CONTACT: Jena Fetalino (63)9178150324 jena@jfprc.com

Prof. David Sweanor, one of the study's authors
"We have seen the most rapid decline in cigarette sales ever witnessed in a major market."

Related Links
International journal of Environmental Research and Public Health https://www.newsfilecorp.com/redirect/naABf5xr

Copyright 2020 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Captiva Verde Land Corp – Corporate Update

Vancouver, BC, Feb 27, 2020 – (ACN Newswire) – Captiva Verde Land Corp. (CSE: PWR) (OTC: CPIVF) (the "Company" or "Captiva"), is pleased to announce the following updates for each of its business segments.

Mexico Pharmaceutical License

Captiva has started construction on its new manufacturing plant in Mexico to supply a wide range of psychoactive, heath and wellness, and narcotic medicines pursuant to our comprehensive pharmaceutical license to sell and distribute over 300 different types of psychoactive (psilocybin) and non-psychoactive (CBD) products. The plant will be finished in June and ready to produce in October of this year for positive accretive cash flow. Further, we have an arrangement to sell all of our products to the Union of Health Care Workers plus the larger group within the Union Federation, as a buying club of 1.2 Million members. Our products will be exceptional quality but priced for the Mexico market in the price range affordable in Mexico at a special discounted price for the benefit of the Union members and their families. This is a long term and sustainable strategy.

Solargram Farms

As stated in our previous news releases, one of the few remaining value propositions in the Cannabis business is to blow up the current status quo of high priced indoor cultivation with extremely low cost high quality outdoor grow. Last year, four (4) public companies produced only 3% of the legal Cannabis supply in Canada with outdoor grow operations. Their respective public disclosures list their total cost to produce at between 10 and 24 cents per gram vs $1.00 to $13.00 per gram for indoor grow, not including their destructively high G&A costs. Solargram was built to supply compassionate Cannabis at retail values well below that of the grey market, which grey market stubbornly controls 75% of the market share. The Solargram operations are almost complete and ready to commence licensed operations in early May with a very large ultra-low cost harvest ready for sale in October of this year.

Miss Envy

Miss Envy is an award winning health and wellness organization with the biggest selection of organic products in the market. Captiva has the world-wide rights outside of Canada. Captiva is currently developing the Miss Envy product line in Mexico to coordinate with the opening of our Mexican facility in June of this year. Miss Envy provides another one of the remaining value added propositions left in the industry, which is a world recognized brand with a huge following. Every time any other LP in the US or Canada sells a Cannabis product, they sell at a loss according to their public disclosures. This is not sustainable. Miss Envy offers a sustainable and profitable solution to the compassionate needs of the industry.

Meanwhile, Captiva is in the process of tweaking Miss Envy's product lines to better appeal to Asian consumers and exploring opportunities to procure substantial sales from the Asian community with Miss Envy, where the products and themes are very well received. Updates will be released as they become available.

Sage Ranch, California

Captiva owns 50% of the sustainable and affordable one-thousand (1,000) housing unit Sage Ranch subdivision in Southern California. The project will have its final California Environmental Impact Report issued on March 4th for the 45 day public review period and then approval in front of the Planning Commission and City Counsel in June of this year. Upon approvals and completion of a 30 day appeal period, construction will commence at the annualized rate of 150 to 250 homes per year.

Summary

Captiva Verde is a highly efficient, nimble, extremely low overhead, high impact and sustainable socially responsible investment company with a multitude of high value projects that will all succeed due to a very loyal shareholder base and an execution oriented, sharply focused and dedicated management team.

On Behalf of the Board of Directors
"Jeffrey Ciachurski"

For further information, please contact:
Jeffrey Ciachurski
Chief Executive Officer and Director
Cell: (949) 903-5906
E-mail: westernwind@shaw.ca

Cautionary Note Regarding Forward Looking Information

This release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include regulatory actions, market prices, and continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/52846

Copyright 2020 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Bayer, Meiogenix Collaborate to Accelerate Agricultural Innovation Through the Development of Unique Technologies

Monheim, Germany and Paris, France, Feb 10, 2020 – (ACN Newswire) – Bayer and Meiogenix, a biotech company focused on next-generation breeding technologies, announced today a collaboration to advance agricultural research and development by accelerating the development of Meiogenix's proprietary technologies related to plant breeding and genome editing applications. This new research collaboration has the potential to deliver much-needed plant health and nutrition improvements to food crops so farmers can more efficiently and sustainably grow improved plant varieties that deliver the types of foods consumers want.



Figure 1: Plants Genetic Diversity – To view an enhanced version of Figure 1, please visit: https://orders.newsfilecorp.com/files/6942/52265_3248f08fd41dbbdb_001full.jpg



"Farmers need innovative solutions as they face limited natural resources and a changing climate," said Jeremy Williams, Head of Plant Biotechnology, Crop Science Research & Development (R&D) at Bayer. "Access to Meiogenix's proprietary technologies could improve the precision and speed with which our breeders enhance crops, which could ultimately accelerate those solutions for the diverse needs of people and our planet."

Meiogenix's proprietary technologies are used to induce the exchange of genomic regions between chromosomes of plant cells during meiosis, the natural process that generates genetic diversity during plant breeding. Technologies based on meiotic recombination provide commercial crops with access to a broader genetic diversity, including complex traits for improved food quality, plants' resistance to diseases and pests, and higher yield potential. The resulting hybrids and varieties have the potential to deliver value throughout the food chain, from farmers to consumers.

"Over the past decade, we have assembled unique know-how, intellectual property portfolio and network of experts to help generate biodiversity and accelerate breeding through modulating meiotic recombination. We are proud to collaborate with Bayer to develop the next generations of crops," said Giacomo Bastianelli, Co-founder & CEO of Meiogenix.

"Agriculture is facing the challenge of adjusting plant physiology to rapid climate, pest and disease changes, as well as preparing the next generation of healthier food. Collaborating on these new breeding technologies will be key to bringing innovative solutions to farmers and consumers," said Luc Mathis, strategic advisor of Meiogenix.

As part of the project, Meiogenix will collaborate with top academic institutes to advance these technologies in crops.

Bayer offers a wide range of educational materials regarding plant breeding and gene editing technologies on its website.

Find more information at www.bayer.com and at www.meiogenix.com

Press Contact
Bayer: Holger Elfes, +49 2173 38-3270, holger.elfes@bayer.com
Meiogenix: Caroline Carmagnol, +33 6 64 18 99 59, caroline@alizerp.com

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties, and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Related Links
Meiogenix Technologies https://www.newsfilecorp.com/redirect/bL0xiyao
Breeding and gene editing at Bayer https://www.newsfilecorp.com/redirect/3ALgsvEX

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/52265

Copyright 2020 ACN Newswire. All rights reserved. http://www.acnnewswire.com